title: Nanoparticle-based vaccine delivery for cancer immunotherapy.
abstract: Development of nano-sized carriers including nanoparticles, nanoemulsions or liposomes holds great potential for advanced delivery systems for cancer immunotherapy, as such nanostructures can be used to more effectively manipulate or deliver immunologically active components to specific target sites. Successful development of nanotechnology based platform in the field of immunotherapy will allow the application of vaccines, adjuvants and immunomodulatory drugs that improve clinical outcomes for immunological diseases. Here, we review current nanoparticle-based platforms in the efficacious delivery of vaccines in cancer immunotherapy.
authors.affiliation: Department of Immunology, School of Medicine, Konkuk University, Chungju 380-701, Korea.
authors.forename: Yeong-Min
authors.initials: YM
authors.lastname: Park
authors.forename: Seung Jun
authors.initials: SJ
authors.lastname: Lee
authors.forename: Young Seob
authors.initials: YS
authors.lastname: Kim
authors.forename: Moon Hee
authors.initials: MH
authors.lastname: Lee
authors.forename: Gil Sun
authors.initials: GS
authors.lastname: Cha
authors.forename: In Duk
authors.initials: ID
authors.lastname: Jung
authors.forename: Tae Heung
authors.initials: TH
authors.lastname: Kang
authors.forename: Hee Dong
authors.initials: HD
authors.lastname: Han
keywords: Cancer; Immunotherapy; Nanoparticle; Vaccine